Atara Biotherapeutics, Inc. (ATRA) Social Stream
ATARA BIOTHERAPEUTICS INC (ATRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ATARA BIOTHERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 7 | $31 | $26 | $27.8 | $0.603 | 4510.28% |
| 2021-12-09 | 7 | $31 | $26 | $28 | $0.603 | 4543.45% |
| 2021-12-13 | 6 | $31 | $26 | $28 | $0.603 | 4543.45% |
| 2021-12-15 | 5 | $31 | $24 | $27.25 | $0.603 | 4419.07% |
| 2022-01-24 | 5 | $31 | $24 | $27.5 | $0.603 | 4460.53% |
| 2022-01-26 | 5 | $31 | $25 | $27.75 | $0.603 | 4501.99% |
| 2022-02-23 | 5 | $31 | $25 | $27 | $0.603 | 4377.61% |
| 2022-03-01 | 5 | $31 | $20 | $25.75 | $0.603 | 4170.32% |
| 2022-05-05 | 4 | $31 | $18 | $24 | $0.603 | 3880.1% |
| 2022-05-12 | 5 | $31 | $8 | $20.8 | $0.603 | 3349.42% |
| 2022-05-23 | 7 | $29 | $8 | $20 | $0.603 | 3216.75% |
| 2022-05-24 | 7 | $29 | $4 | $17.333 | $0.603 | 2774.46% |
| 2022-07-25 | 7 | $50 | $3 | $17.857 | $0.603 | 2861.36% |
| 2022-08-09 | 7 | $50 | $3 | $17.757 | $0.603 | 2844.78% |
| 2022-08-15 | 8 | $50 | $3 | $17.042 | $0.603 | 2726.2% |
| 2022-11-09 | 8 | $50 | $3 | $18.787 | $0.603 | 3015.59% |
| 2022-11-15 | 8 | $50 | $3 | $18.75 | $0.603 | 3009.45% |
| 2023-01-05 | 8 | $50 | $3 | $18.875 | $0.603 | 3030.18% |
| 2023-04-05 | 8 | $50 | $3 | $18.625 | $0.603 | 2988.72% |
| 2023-05-09 | 9 | $31 | $3 | $14.875 | $0.603 | 2366.83% |
| 2023-06-14 | 8 | $31 | $3 | $16.7 | $0.603 | 2669.49% |
| 2023-08-09 | 7 | $31 | $4.9 | $18.983 | $0.603 | 3048.09% |
| 2023-08-21 | 7 | $31 | $1.4 | $16.471 | $0.603 | 2631.51% |
| 2023-09-26 | 7 | $31 | $1.4 | $18.383 | $0.603 | 2948.59% |
| 2023-11-01 | 7 | $31 | $1.4 | $18.366 | $0.603 | 2945.77% |
| 2023-11-13 | 9 | $25 | $1 | $9.04 | $0.603 | 1399.17% |
| 2023-11-22 | 9 | $13 | $0.4 | $3.94 | $0.603 | 553.4% |
The Trend in the Analyst Price Target
Over the past 24 months, ATRA's average price target has gone down $23.31.
ATRA reports an average of 1,076.74% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-09 | 8 | 50 | 3.0 | 18.625 | 4.770 | 290.46% |
| 2023-04-05 | 8 | 50 | 3.0 | 18.625 | 2.780 | 569.96% |
| 2023-08-21 | 7 | 31 | 1.4 | 16.471 | 1.410 | 1068.16% |
| 2023-09-26 | 8 | 31 | 1.4 | 16.471 | 1.570 | 949.11% |
| 2023-11-22 | 8 | 13 | 0.4 | 3.940 | 0.572 | 588.81% |
ATRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.78 | 3 | 0 | 4 | 2 | 2 | 9 |
The Trend in the Broker Recommendations
ATRA's average broker recommendation rating worsened by 1.75 over the prior 22 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATRA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ATARA BIOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 4060.9% of them.
- To contextualize these metrics, consider that out of all US stocks, ATARA BIOTHERAPEUTICS INC's variance in analysts' estimates is lower than -3107.52% of them.
- In the context of stocks in the small market cap category, ATARA BIOTHERAPEUTICS INC's number of analysts covering the stock is greater than 3229.38% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, ATARA BIOTHERAPEUTICS INC's average analyst price target is greater than 1338.87% of them.
Stocks similar to ATARA BIOTHERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CGEN, ONVO, and XTNT.
View All Top Stocks by Price Target
Make investment decisions regarding ATRA using the data that counts. Try POWR Ratings for free.